Manufacturer of Controlled Substances Registration: Sigma Aldrich Research Biochemicals, Inc., 73629 [2014-29119]

Download as PDF Federal Register / Vol. 79, No. 238 / Thursday, December 11, 2014 / Notices of the listed controlled substances in bulk and to conduct analytical testing in support of the company’s primary manufacturing facility in West Deptford, New Jersey. The controlled substances manufactured in bulk at this facility will be distributed to the company’s customers. Dated: November 25, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2014–29117 Filed 12–10–14; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–392] Manufacturer of Controlled Substances Registration: Sigma Aldrich Research Biochemicals, Inc. Drug Enforcement Administration, Department of Justice. ACTION: Notice of registration. AGENCY: Sigma Aldrich Research Biochemicals, Inc., applied to be registered as a manufacturer of certain basic classes of controlled substances. The DEA grants Sigma Aldrich Research Biochemicals, Inc. registration as a manufacturer of those controlled substances. SUMMARY: By notice dated January 15, 2014, and published in the Federal Register on February 4, 2014, 79 FR 6633, Sigma Aldrich Research Biochemicals, Inc. 1–3 Strathmore Road, Natick, Massachusetts 01760–2447, applied to be registered as a manufacturer of certain basic classes of controlled substances. No comments or objections were submitted to this notice. The Drug Enforcement Administration (DEA) has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Sigma Aldrich Research Biochemicals, Inc. to manufacture the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated the company’s maintenance of effective controls against diversion by inspecting and testing the company’s physical security systems, verifying the company’s compliance with state and local laws, and reviewing the company’s background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the above named company is mstockstill on DSK4VPTVN1PROD with NOTICES SUPPLEMENTARY INFORMATION: VerDate Sep<11>2014 19:07 Dec 10, 2014 Jkt 235001 granted registration as a bulk manufacturer of the basic classes of controlled substances listed: 73629 Dated: November 25, 2014. Joseph T. Rannazzisi, Deputy Assistant Administrator. [FR Doc. 2014–29119 Filed 12–10–14; 8:45 am] Controlled substance Cathinone (1235) .......................... Methcathinone (1237) .................. Mephedrone (4-Methyl-Nmethylcathinone) (1248). Aminorex (1585) ........................... Alpha-ethyltryptamine (7249) ....... Lysergic acid diethylamide (7315) Tetrahydrocannabinols (7370) ..... 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). 3,4-Methylenedioxyamphetamine (7400). N-Hydroxy-3,4methylenedioxyamphetamine (7402). 3,4-Methylenedioxy-Nethylamphetamine (7404). 3,4Methylenedioxymethamphetamine (MDMA) (7405). Dimethyltryptamine (7435) ........... Psilocybin (7437) .......................... 5-Methoxy-N, Ndiisopropyltryptamine (7439). 1-[1-(2Thienyl)cyclohexyl]piperidine (TCP) (7470). N-Benzylpiperazine (BZP) (7493) MDPV (3,4Methylenedioxypyrovalerone) (7535). Methylone (3,4-Methylenedioxy-Nmethylcathinone) (7540). Heroin (9200) ............................... Normorphine (9313) ..................... Amphetamine (1100) .................... Methamphetamine (1105) ............ Nabilone (7379) ............................ 1-Phenylcyclohexylamine (7460) Phencyclidine (7471) .................... Cocaine (9041) ............................. Codeine (9050) ............................. Ecgonine (9180) ........................... Levomethorphan (9210) ............... Levorphanol (9220) ...................... Meperidine (9230) ........................ Metazocine (9240) ........................ Methadone (9250) ........................ Morphine (9300) ........................... Thebaine (9333) ........................... Levo-alphacetylmethadol (9648) .. Remifentanil (9739) ...................... Sufentanil (9740) .......................... Carfentanil (9743) ......................... Fentanyl (9801) ............................ Schedule I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II The company plans to manufacture reference standards. PO 00000 Frm 00088 Fmt 4703 Sfmt 4703 BILLING CODE 4410–09–P DEPARTMENT OF LABOR Employee Benefits Security Administration Proposed Extension of Information Collection Request Submitted for Public Comment; Revisions to Coverage of Certain Preventive Services Under the Affordable Care Act Employee Benefits Security Administration, Department of Labor. ACTION: Notice. AGENCY: The Department of Labor (the Department), in accordance with the Paperwork Reduction Act of 1995 (PRA 95) (44 U.S.C. 3506(c)(2)(A)), provides the general public and Federal agencies with an opportunity to comment on proposed and continuing collections of information. This helps the Department assess the impact of its information collection requirements and minimize the reporting burden on the public and helps the public understand the Department’s information collection requirements and provide the requested data in the desired format. Currently, the Employee Benefits Security Administration is soliciting comments on the revision of the Coverage of Certain Preventive Services Under the Affordable Care Act information collection to reflect the new option of notifying the Department of Health and Human Services of the respondents’ objections to providing coverage in response to the Supreme Court of the United States’ interim order in connection with an application for an injunction in the pending case of Wheaton College v. Burwell. A copy of the information collection request (ICR) may be obtained by contacting the office listed in the ADDRESSES section of this notice. DATES: Written comments must be submitted to the office shown in the Addresses section on or before February 9, 2015. ADDRESSES: Direct all written comments regarding the information collection request and burden estimates to G. Christopher Cosby, Office of Policy and Research, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue NW., Room N–5718, Washington, DC 20210. Telephone: (202) 693–8410; Fax: (202) SUMMARY: E:\FR\FM\11DEN1.SGM 11DEN1

Agencies

[Federal Register Volume 79, Number 238 (Thursday, December 11, 2014)]
[Notices]
[Page 73629]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-29119]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Manufacturer of Controlled Substances Registration: Sigma Aldrich 
Research Biochemicals, Inc.

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: Sigma Aldrich Research Biochemicals, Inc., applied to be 
registered as a manufacturer of certain basic classes of controlled 
substances. The DEA grants Sigma Aldrich Research Biochemicals, Inc. 
registration as a manufacturer of those controlled substances.

SUPPLEMENTARY INFORMATION: By notice dated January 15, 2014, and 
published in the Federal Register on February 4, 2014, 79 FR 6633, 
Sigma Aldrich Research Biochemicals, Inc. 1-3 Strathmore Road, Natick, 
Massachusetts 01760-2447, applied to be registered as a manufacturer of 
certain basic classes of controlled substances. No comments or 
objections were submitted to this notice.
    The Drug Enforcement Administration (DEA) has considered the 
factors in 21 U.S.C. 823(a) and determined that the registration of 
Sigma Aldrich Research Biochemicals, Inc. to manufacture the basic 
classes of controlled substances is consistent with the public interest 
and with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. The DEA 
investigated the company's maintenance of effective controls against 
diversion by inspecting and testing the company's physical security 
systems, verifying the company's compliance with state and local laws, 
and reviewing the company's background and history.
    Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 
CFR 1301.33, the above named company is granted registration as a bulk 
manufacturer of the basic classes of controlled substances listed:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Cathinone (1235)...........................  I
Methcathinone (1237).......................  I
Mephedrone (4-Methyl-N-methylcathinone)      I
 (1248).
Aminorex (1585)............................  I
Alpha-ethyltryptamine (7249)...............  I
Lysergic acid diethylamide (7315)..........  I
Tetrahydrocannabinols (7370)...............  I
4-Bromo-2,5-dimethoxyamphetamine (7391)....  I
4-Bromo-2,5-dimethoxyphenethylamine (7392).  I
4-Methyl-2,5-dimethoxyamphetamine (7395)...  I
2,5-Dimethoxyamphetamine (7396)............  I
3,4-Methylenedioxyamphetamine (7400).......  I
N-Hydroxy-3,4-methylenedioxyamphetamine      I
 (7402).
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-Methylenedioxymethamphetamine (MDMA)     I
 (7405).
Dimethyltryptamine (7435)..................  I
Psilocybin (7437)..........................  I
5-Methoxy-N, N-diisopropyltryptamine (7439)  I
1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP)  I
 (7470).
N-Benzylpiperazine (BZP) (7493)............  I
MDPV (3,4-Methylenedioxypyrovalerone)        I
 (7535).
Methylone (3,4-Methylenedioxy-N-             I
 methylcathinone) (7540).
Heroin (9200)..............................  I
Normorphine (9313).........................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Nabilone (7379)............................  II
1-Phenylcyclohexylamine (7460).............  II
Phencyclidine (7471).......................  II
Cocaine (9041).............................  II
Codeine (9050).............................  II
Ecgonine (9180)............................  II
Levomethorphan (9210)......................  II
Levorphanol (9220).........................  II
Meperidine (9230)..........................  II
Metazocine (9240)..........................  II
Methadone (9250)...........................  II
Morphine (9300)............................  II
Thebaine (9333)............................  II
Levo-alphacetylmethadol (9648).............  II
Remifentanil (9739)........................  II
Sufentanil (9740)..........................  II
Carfentanil (9743).........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture reference standards.

    Dated: November 25, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-29119 Filed 12-10-14; 8:45 am]
BILLING CODE 4410-09-P